|
TPST Tempest Therapeutics Inc 1544227 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-5,244,000.00 |
| Balance Sheet |
|
Current Assets
|
$1,697,000.00 |
|
Assets
|
$9,633,000.00 |
|
Current Liabilities
|
$4,450,000.00 |
|
Liabilities
|
$10,723,000.00 |
|
Equity
|
$-1,090,000.00 |
|
Shares Out
|
15979411.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-10,377,000.00 |
| Market Analysis |
Market Cap
|
$16,298,999.22 |
|
Price
|
$1.02 |
|
BVPS
|
0.06 |
|
PB
|
17.00 |
|
EPS
|
-0.34 |
|
FCF
|
$-10,377,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:58 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:49 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-6.33 |
|
|
2026-05-14 |
-2.53 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-2.07 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.79 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TPST documents filed with the SEC.
TPST Filings
Clear
